MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/mds.29691

Медицинская библиотека · Movement disorders : official journal of the Movement Disorder Society · 2023

Embedding Patient Input in Outcome Measures for Long-Term Disease-Modifying Parkinson Disease Trials.

Gonzalez-Robles Cristina, Bartlett Michèle, Burnell Matthew, Clarke Caroline S, Haar Shlomi, Hu Michele T, Huxford Brook, Jha Ashwani, Lawton Michael, Noyce Alastair, Piccini Paola, Pushparatnam Kuhan, Rochester Lynn, Siu Carroll, van Wamelen Daniel, Williams-Gray Caroline H, Zeissler Marie-Louise, Zetterberg Henrik, Carroll Camille B, Foltynie Thomas, Weil Rimona S, Schrag Anette, EJS ACT-PD Consortium

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Clinical trials of disease-modifying therapies in PD require valid and responsive primary outcome measures that are relevant to patients.

OBJECTIVES

The objective is to select a patient-centered primary outcome measure for disease-modification trials over three or more years.

METHODS

Experts in Parkinson's disease (PD), statistics, and health economics and patient and public involvement and engagement (PPIE) representatives reviewed and discussed potential outcome measures. A larger PPIE group provided input on their key considerations for such an endpoint. Feasibility, clinimetric properties, and relevance to patients were assessed and synthesized.

RESULTS

Although initial considerations favored the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III in Off, feasibility, PPIE input, and clinimetric properties supported the MDS-UPDRS Part II. However, PPIE input also highlighted the importance of nonmotor symptoms, especially in the longer term, leading to the selection of the MDS-UPDRS Parts I + II sum score.

CONCLUSIONS

The MDS-UPDRS Parts I + II sum score was chosen as the primary outcome for large 3-year disease-modification trials. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Для цитирования: Gonzalez-Robles Cristina, Bartlett Michèle, Burnell Matthew, Clarke Caroline S, Haar Shlomi, Hu Michele T, Huxford Brook, Jha Ashwani, Lawton Michael, Noyce Alastair, Piccini Paola, Pushparatnam Kuhan, Rochester Lynn, Siu Carroll, van Wamelen Daniel, Williams-Gray Caroline H, Zeissler Marie-Louise, Zetterberg Henrik, Carroll Camille B, Foltynie Thomas, Weil Rimona S, Schrag Anette, EJS ACT-PD Consortium. Embedding Patient Input in Outcome Measures for Long-Term Disease-Modifying Parkinson Disease Trials.. Movement disorders : official journal of the Movement Disorder Society. 2023. DOI: 10.1002/mds.29691.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.